We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
276
United Therapeutics
UTHR
$22.8B
$1.18M 0.09%
+2,814
New +$946K
EQH icon
277
Equitable Holdings
EQH
$14.5B
$1.16M 0.09%
22,891
+1,661
+8% +$88K
GLPI icon
278
Gaming and Leisure Properties
GLPI
$12.5B
$1.16M 0.09%
24,913
+18
+0.1% +$848
IMXI icon
279
International Money Express
IMXI
$361M
$1.16M 0.09%
+82,896
New +$1.03M
OKLO
280
Oklo
OKLO
$7.87B
$1.15M 0.09%
+10,345
New +$810K
C icon
281
Citigroup
C
$227B
$1.15M 0.09%
11,308
+6,810
+151% +$646K
GENI icon
282
Genius Sports
GENI
$2.13B
$1.15M 0.09%
92,529
+1,181
+1% +$14.1K
EAT icon
283
Brinker International
EAT
$9.74B
$1.14M 0.09%
9,025
+2,255
+33% +$352K
AXON
284
Axon Enterprise
AXON
$48.2B
$1.14M 0.09%
1,584
+637
+67% +$483K
AVDX
285
DELISTED
AvidXchange
AVDX
$1.14M 0.09%
114,226
RSI icon
286
Rush Street Interactive
RSI
$2.88B
$1.13M 0.09%
55,337
-29,936
-35% -$565K
MP icon
287
MP Materials
MP
$9.82B
$1.13M 0.09%
16,869
+1,094
+7% +$68.8K
ANF icon
288
Abercrombie & Fitch
ANF
$5.24B
$1.12M 0.09%
13,139
-90,632
-87% -$8.46M
MPWR icon
289
Monolithic Power Systems
MPWR
$68.3B
$1.11M 0.09%
1,210
-1,996
-62% -$1.62M
TVTX icon
290
Travere Therapeutics
TVTX
$5.79B
$1.11M 0.09%
46,407
-2,650
-5% -$49.8K
SLNO
291
DELISTED
Soleno Therapeutics
SLNO
$1.11M 0.09%
16,393
+2,484
+18% +$184K
MNDY icon
292
monday.com
MNDY
$3.69B
$1.09M 0.09%
5,634
+3,218
+133% +$741K
VRT icon
293
Vertiv
VRT
$104B
$1.09M 0.09%
7,233
+1,317
+22% +$176K
CLSK icon
294
CleanSpark
CLSK
$3.08B
$1.09M 0.08%
+75,056
New +$847K
STNG icon
295
Scorpio Tankers
STNG
$3.77B
$1.08M 0.08%
19,219
-781
-4% -$38.5K
CACI icon
296
CACI
CACI
$14B
$1.07M 0.08%
2,152
+1,672
+348% +$808K
CFLT
297
DELISTED
Confluent
CFLT
$1.06M 0.08%
53,687
+3,453
+7% +$72.2K
WBS icon
298
Webster Financial
WBS
$12.8B
$1.05M 0.08%
+17,701
New +$1.05M
BMY icon
299
Bristol-Myers Squibb
BMY
$133B
$1.05M 0.08%
+23,275
New +$1.09M
CP icon
300
Canadian Pacific Kansas City
CP
$80.3B
$1.04M 0.08%
+14,026
New +$1.07M

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.